What is PCOS?

What is PCOS?

Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.

At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.

So, how can the PCOS Association help?

We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.

Here’s what you’ll find at PCOSA:

  • Reliable, science-backed information about what PCOS is (and isn’t)

  • 💬 Supportive communities of people who understand exactly what you’re going through

  • 🧬 Resources for navigating fertility, metabolic health, nutrition, and more

  • 🧠 Education for providers who want to better support their PCOS patients

  • 🙋‍♀️ Advocacy to make sure PCOS is recognized, researched, and respected

No fluff. No fad cures. Just real support, grounded in evidence and compassion.

At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.

pcos

pcos: Latest results from PubMed

Protocol flexibility in PCOS: a combination of controlled ovarian stimulation and endometrial preparation strategies shows no impact on live birth outcomes after frozen embryo transfer-a retrospective cohort study

CONCLUSIONS: For PCOS patients, live birth success is equivalent regardless of COS/FET protocol combination, supporting flexible treatment personalization. Clinical decision-making involves a critical trade-off: GnRH agonist protocols and ovulation FET cycles may be associated with a trend toward lower obstetric morbidity, potentially linked to the promotion of a more physiological ovulatory milieu. This balance between immediate iatrogenic risk and long-term pregnancy health warrants further...

Published on: Sat, 04 Apr 2026 06:00:00 -0400

Authors: Dongdong Chen, Ming-Hui Chen, Zeng-Yan Wang, Lu Luo, Yanwen Xu, Dan Zhang,

Synergistic Interplay of Acceptor and Isovalent Co-Doping on BaZrO3-Based Proton Conducting Oxides: A First-Principles Study

Acceptor-doped BaZrO(3) (BZO) with an ABO3-type structure is a promising proton-conducting oxide (PCO) for fuel cells and electrolyzers. However, dehydration at elevated temperatures significantly reduces proton concentration, hindering commercialization. While recent studies have shown that isovalent co-doping in acceptor-doped systems improves hydration performance, the dehydration remains unresolved due to a lack of fundamental understanding of these co-doping effects. In this study,...

Published on: Sat, 04 Apr 2026 06:00:00 -0400

Authors: Yonghun Shin, Kyung-Yeon Doh, June Ho Lee, Shin Hyun Kim, Donghwa Lee,

Evaluation of a fluorescent-based point-of-care AMH assay: A bicentric assessment of analytical performance, method agreement, and usability

CONCLUSIONS: The fluorescent-based AMH POCT assay demonstrated acceptable analytical performance, strong correlation with a routine laboratory method, and favourable usability. However, until harmonisation across methods is achieved, cautious interpretation and confirmatory laboratory testing remain essential when results are close to clinical decision thresholds.

Published on: Sat, 04 Apr 2026 06:00:00 -0400

Authors: Ali Khatib, Damien Gruson, Iman Azariouh, Soukayna Draoui, Wearm Zreikat, Gheyath K Nasrallah,

Eating attitudes, sleep quality, and self-esteem in adolescents diagnosed with polycystic ovary syndrome

OBJECTIVE: To investigate the risk of eating disorders, poor sleep quality and low self-esteem in adolescents with polycystic ovary syndrome (PCOS) in comparison with a healthy group and to determine how these factors are related to each other as well as which disease characteristics may influence them.

Published on: Sat, 04 Apr 2026 06:00:00 -0400

Authors: Ozlem Ketenci Altikardesler, Ozlem Dural, Ipek Evruke, Hevra Ekin Ulusoy, Melike Zeynep Tugrul Aksakal, Firdevs Bas,

PCOS in women with normal body mass index is not associated with adverse obstetric and perinatal outcomes after IVF-FET

CONCLUSIONS: Among women with normal BMI, PCOS is not associated with increased obstetric and perinatal complications compared with controls following FET.

Published on: Fri, 03 Apr 2026 06:00:00 -0400

Authors: Qiuyu Xu, Shuwen Qiu, Xiaoyan Mao, Ling Wu, Jie Zhang,

Inflammation-Driven Pathogenesis of Polycystic Ovary Syndrome: Integrating Endocrine Imbalance, Reproductive Impairments, and Tissue-Level Change

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age, classically defined by hyperandrogenism, ovulatory dysfunction and polycystic ovaries morphology. Recent findings now support that low-grade chronic inflammation is a key player in PCOS pathophysiology, explaining hormonal, metabolic, and reproductive dysfunction.

Published on: Fri, 03 Apr 2026 06:00:00 -0400

Authors: Manthan Suthar, Vitalii Kaliberdenko,

Bidirectional and Multivariable Mendelian Randomization Study of PCOS and VTE

CONCLUSION: Genetic evidence does not support a causal relationship between PCOS and VTE. BMI is independently associated with VTE risk and appears to be a key determinant of VTE risk.

Published on: Fri, 03 Apr 2026 06:00:00 -0400

Authors: Lifang You, Hongyin Cui, Fen Zhao, Hairong Huang, Wenxuan Xu,

Social deprivation, race, and metabolic syndrome in patients with polycystic ovary syndrome

CONCLUSION: High social deprivation is associated with increased risk of new-onset MetSyn and may contribute to the higher risk in Black compared to White women with PCOS. These results highlight the importance of considering SDoH, particularly in an already high-risk population.

Published on: Fri, 03 Apr 2026 06:00:00 -0400

Authors: Iris T Lee, Shakira King, Naria Sealy, John Rees, Sunni L Mumford, Stefanie N Hinkle, Anuja Dokras,

Effect of a 5:2 intermittent fasting diet on obese patients with polycystic ovary syndrome

CONCLUSIONS: The 5:2 intermittent fasting diet with MR significantly reduces body weight, improves insulin sensitivity, and enhances metabolic markers in obese women with PCOS. Although reproductive hormone levels did not significantly change, menstrual and ovulatory function improved. Future studies with larger sample sizes and longer follow-up are needed to explore the long-term effects of intermittent fasting on reproductive health in PCOS patients.

Published on: Fri, 03 Apr 2026 06:00:00 -0400

Authors: Wencheng An, Fang Chen, Bingyan Wang, Shujing Zhou, Lin Jiang, Bo An, Zhijun Cui, Xiaohong Ou, Wei Huang, Huixian Yan,

Artificial Intelligence-Guided Optimization of Hyaluronic Acid-Coated Liposomal Linagliptin for Targeted Management of Polycystic Ovary Syndrome

Linagliptin, a DPP-4 inhibitor commonly used in the management of diabetes mellitus, has shown potential activity in polycystic ovary syndrome (PCOS). Linagliptin's therapeutic effectiveness is limited by its poor membrane permeability and low oral bioavailability. This study aimed to formulate hyaluronic acid-coated liposomal linagliptin optimized through I-optimal design and AI-based entrapment efficiency (EE%) prediction. The effects of hyaluronic acid and drug concentrations on particle size...

Published on: Thu, 02 Apr 2026 06:00:00 -0400

Authors: Marwa H S Dawoud, Aml H Zaghloul, Karen S Zakhari, Mai I Mahmoud, Zeinab M Elnagdy, Nyera H El-Shafei, Mai A Zaafan,

Exploring the impact of Ramadan fasting on women's reproductive health: A narrative review

Ramadan is the ninth month of the Islamic lunar calendar in which Muslims abstain from consumption of food and drink, smoking, and engaging in sexual activity during daylight hours for the full lunar month, approximately 29-30 days. Beyond its spiritual significance, fasting during this month represents a distinct physiologic and cultural practice that may influence women's reproductive health. This narrative review integrates findings from published studies to summarize current evidence on the...

Published on: Thu, 02 Apr 2026 06:00:00 -0400

Authors: Sehar Hussain, Sana Ahsan, Alysha Ali, Hira Khan, Sedra Tibi, Hina Mohsin,

A distinct plasma lipidomic signature and multi-omics network in depression of polycystic ovary syndrome

Patients with polycystic ovary syndrome (PCOS) are at an elevated risk of depression, yet the underlying mechanisms remain elusive. Emerging evidence implicates the gut-brain axis and systemic lipid homeostasis alterations as potential key contributors. We profiled untargeted plasma lipidomes of PCOS patients with and without comorbid depression (PCOS-DP) and integrated these data with our prior gut microbial and host transcriptomic datasets to construct multi-omics interaction networks. The...

Published on: Thu, 02 Apr 2026 06:00:00 -0400

Authors: Furong Yan, Ming Sui, Hongzhi Gao, Yifei Liu, Liying Yu,

Assessment of Functional Capacity and Fatigue Severity in Young Women With Polycystic Ovary Syndrome: A Cross-Sectional Study

CONCLUSION: PCOS does not significantly impact VO(2) max in young females, although they showed mildly lower VO(2) max and mild to moderate fatigue levels compared to healthy individuals. Further research is needed to assess the impact of chronic PCOS on these variables.

Published on: Thu, 02 Apr 2026 06:00:00 -0400

Authors: Satani Kalpesh, Janavi Sanghani, Palani G Kumar,

The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation

No abstract

Published on: Wed, 01 Apr 2026 06:00:00 -0400

Authors: Christo Albor, Oluwaseun Anyiam, Luke D Boyle, Janine Makaronidis, Rachael Tan, Sahar Iftikhar, Amna Burzic, Fannie Lajeunesse Trempe, Moira Stanley, Aniqah Bhatti, Jadine Scragg, Layla Badawy, Komal Moqeem, Iskandar Idris, Rob C Andrews, Piya Sen Gupta, David Hughes, Katherine McCullough, Tricia Tan, Barbara McGowan,

Global Trends and Burden of Non-Neoplastic Gynecologic Diseases Among Women of Childbearing Age, 1990-2021: a GBD 2021 Analysis

CONCLUSION: The global burden of non-neoplastic gynecological diseases among WCBA remains substantial, with marked heterogeneity across regions and conditions. These findings underscore the importance of strengthened disease surveillance, improved and equitable access to reproductive health services, and greater integration of mental health support in women's health strategies.

Published on: Wed, 01 Apr 2026 06:00:00 -0400

Authors: Zhaochen Sun, Hao Liu, Nan Wang, Ping Sun, Liangwei Wu, Erxu Xue, Yan Chen, Jianhui Zhao, Kaihong Zeng, Yuping Liu, Zhengwei Wan, Yunli Ye,